Clinical Decision Support
MDCalc CrossCover
Independent evidence and privacy checks around participating clinical AI tools.
The Signal
MDCalc launched CrossCover on November 11, 2026 as an independent safety layer for clinical AI. CrossCover adds evidence checks, privacy safeguards and MDCalc tools around participating AI responses while keeping physicians in control. AMBOSS and Vera Health are founding partners; ECRI and the American College of Physicians are inaugural content providers. The Charter Physician program launches first in the United States, with identity verification through an MDCalc account. Joseph Habboushe, MD is co-founder and CEO.
Company profileMore in Clinical Decision Support
UpToDate
Offers a comprehensive, peer-reviewed clinical decision support resource with evidence-based recommendations.
View toolGlass Health
AI assistant that drafts differential diagnoses and assessment and plans from a case summary.
View toolDynaMed
Provides objective, evidence-based clinical content and decision support for point-of-care medical practice.
View toolMedscape
Offers medical news, drug reference tools, clinical calculators, and continuing medical education resources.
View toolEpocrates
Delivers mobile-optimized drug information, interaction checkers, and clinical practice guidelines at the bedside.
View toolVisualDX
Aids diagnostic accuracy with a comprehensive, peer-reviewed medical image library and clinical search tools.
View tool